Vnitr Lek 2017, 63(5):343-347 | DOI: 10.36290/vnl.2017.069

Salvation of the diabetic foot through a comprehensive individualized treatment of the patient with type 2 diabetes: case study

Ivana Flanderová
Diabetologické centrum II. interní kliniky LF UK v Plzni a FN Plzeň

This is a case of men with type 2 diabetes mellitus and diabetic foot. The patient was in danger of limb amputation. After improvement of diabetes, hypertension and dyslipidemia therapies a comprehensive treatment of diabetic foot including angioplasty, antibiotics and local maggot therapy was used for diabetic foot management. Therapy result was very satisfying for the patient. Despite of amputation of the 2nd digit due to advanced gangrene, the whole foot function was saved.

Keywords: diabetes foot; maggot therapies; type 2 diabetes mellitus

Received: March 29, 2017; Accepted: May 5, 2017; Published: May 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Flanderová I. Salvation of the diabetic foot through a comprehensive individualized treatment of the patient with type 2 diabetes: case study. Vnitr Lek. 2017;63(5):343-347. doi: 10.36290/vnl.2017.069.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Škrha J, Pelikánová T, Kvapil M. Doporučený postup péče o diabetes mellitus 2. typu. ČDS 2016. Dostupné z WWW: <http://www.diab.cz/dokumenty/standard_lecba_dm_typ_II.pdf>.
    2. Bailey CJ, Del Prato S, Eddy D et al. Earlier intervention in type 2 diabetes the case for achieving early and sustained glycaemic control. Int J Clin Pract 2005; 59(11): 1309-1316. Go to original source... Go to PubMed...
    3. Filipovský J, Widimský J Jr, Ceral J et al. Diagnostické a léčebné postupy u arteriální hypertenze - verze 2012. Doporučení České společnosti pro hypertenzi. Vnitř Lék 2012; 58(10): 785-801. Go to PubMed...
    4. Keech AC, Simek RJ, Barter P et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005; 366(9500): 1849-1861. Go to original source... Go to PubMed...
    5. Ginsberg HN, Elam MB, Lovato LC et al. [ACCORD Study Group]. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010; 362(17): 1563-1574. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1001282>. Go to original source... Go to PubMed...
    6. Catapano AL, Graham I, De Backer G et al. [Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)]. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J 2016; 37(39): 2999-3058. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehw272>. Go to original source... Go to PubMed...
    7. Jirkovská A. Syndrom diabetické nohy z pohledu internisty podiatra. Vnitř Lék 2016; 7-8(Suppl 4): S42-S47.
    8. Jirkovská A. Možnosti plnění mezinárodních doporučení terapie syndromu diabetické nohy v České republice. Vnitř Lék 2011; 57(11): 908-912. Go to PubMed...
    9. Jirkovská A, Lacigová S, Rušavý Z et al. Doporučený postup pro prevenci, diagnostiku a terapii syndromu diabetické nohy. Česká diabetologická společnost ČLS JEP. 10.10.2016. Dostupné z WWW: <http://www.diab.cz/dokumenty/standard_diab_noha.pdf>.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.